| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 177.52B | 167.00B | 152.68B | 144.44B | 135.48B | 138.93B |
| Gross Profit | 19.11B | 17.99B | 14.15B | 15.14B | 13.44B | 13.94B |
| EBITDA | 7.72B | 7.52B | 7.94B | 7.61B | 6.21B | 6.83B |
| Net Income | 5.04B | 4.69B | 4.67B | 4.20B | 3.75B | 4.14B |
Balance Sheet | ||||||
| Total Assets | 105.23B | 115.24B | 101.25B | 93.03B | 90.13B | 92.18B |
| Cash, Cash Equivalents and Short-Term Investments | 13.85B | 16.83B | 13.03B | 11.89B | 13.19B | 15.76B |
| Total Debt | 17.18B | 21.56B | 14.98B | 10.33B | 10.68B | 11.03B |
| Total Liabilities | 60.61B | 69.10B | 52.54B | 48.37B | 47.46B | 50.46B |
| Stockholders Equity | 44.23B | 45.71B | 47.62B | 44.00B | 42.20B | 41.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.97B | -3.60B | 1.20B | 366.00M | -13.99B |
| Operating Cash Flow | 0.00 | 5.18B | -3.17B | 1.35B | 1.56B | -12.90B |
| Investing Cash Flow | 0.00 | -784.00M | 2.65B | 934.00M | -2.26B | 815.00M |
| Financing Cash Flow | 0.00 | -913.00M | 1.41B | -3.66B | -2.27B | -1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥74.88B | 11.48 | ― | 3.64% | 15.03% | -4.08% | |
77 Outperform | ¥97.43B | 6.30 | ― | 4.38% | -6.07% | 44.83% | |
73 Outperform | ¥79.60B | 12.54 | ― | 1.25% | 3.44% | -11.78% | |
73 Outperform | ¥82.37B | 24.41 | ― | 0.96% | 2.16% | 35.34% | |
66 Neutral | ¥74.26B | 20.04 | ― | 0.99% | 19.45% | 53.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥79.90B | 12.57 | ― | 8.02% | -2.54% | -32.91% |